Anzeige
❌
Mehr »
Donnerstag, 08.10.2026 - Börsentäglich über 12.000 News
Patent bis 2039: Ist das der nächste große Wachstumstreiber für diese Small-Cap-Aktie?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QEF3 | ISIN: CA98980M1095 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ZOMEDICA CORP Chart 1 Jahr
5-Tage-Chart
ZOMEDICA CORP 5-Tage-Chart

Aktuelle News zur ZOMEDICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ZOMEDICA Aktie jetzt für 0€ handeln
12:02Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on October 23, 2026: Zomedica's Clinical Program: How Evidence Drives Adoption249October session to show how veterinarian-led clinical studies build the evidence behind Zomedica's PulseVet, VetGuardian PLUS, and TRUFORMA product lines, and how that evidence turns into adoption,...
► Artikel lesen
22.09.Zomedica schließt Partnerschaft mit VMG für Zugang zu über 2.000 Tierarztpraxen1
22.09.Zomedica partners with veterinary group for product access2
22.09.Zomedica Corp.: Zomedica Announces Strategic Partnership with Veterinary Study Groups to Deliver Advanced Veterinary Technologies to Independent Practices570New agreement brings innovative diagnostic, shock wave therapy, and remote monitoring solutions to more than 2,000 member practices across the United States ANN ARBOR, MI / ACCESS Newswire / September...
► Artikel lesen
09.09.Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica's Marketing Engine: How Demand Becomes Revenue785September session to spotlight how Zomedica's marketing function creates demand, equips the field, and supports utilization across the company's diagnostic and therapeutic portfolios ANN ARBOR, MI /...
► Artikel lesen
13.08.Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform912Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue in Canada ANN ARBOR, MI...
► Artikel lesen
11.08.Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation868August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents ANN...
► Artikel lesen
05.08.Zomedica Corp. - 8-K, Current Report1
05.08.Zomedica Corp.: Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity543Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue growth to 22 quarters. ANN ARBOR, MI / ACCESS Newswire / August...
► Artikel lesen
05.08.Zomedica Corp. - 10-Q, Quarterly Report3
04.08.Zomedica Corp.: Zomedica Launches the PulseVet Acoustic Muffler Accessory for PulseVet Shock Wave System425The accessory reduces sound in the treatment environment while maintaining the trusted efficacy of PulseVet shock wave therapy ANN ARBOR, MI / ACCESS Newswire / August 4, 2026 / Zomedica Corp. (OTCQB:ZOMDF)...
► Artikel lesen
15.07.Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic560July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR...
► Artikel lesen
25.06.Zomedica Corp.: Zomedica's Assisi Loop Products Designated "Fear Free" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC425Collaboration with Fear Free and Zomedica reinforces Assisi Loop tPEMF therapy as a low-stress option for pets. ANN ARBOR, MI / ACCESS Newswire / June 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"...
► Artikel lesen
11.06.Zomedica Corp. - 8-K, Current Report2
10.06.Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns444June session to present the strategic framework behind every Zomedica product and investment decision, connecting pet care outcomes, veterinary practice performance, and long-term recurring revenue...
► Artikel lesen
20.05.Zomedica Corp.: Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association478Collaboration with USEA for Zomedica's PulseVet shock wave system will increase brand awareness among Eventing enthusiasts. ANN ARBOR, MI / ACCESS Newswire / May 20, 2026 / Zomedica Corp. (OTCQB:ZOMDF)...
► Artikel lesen
14.05.Zomedica Corp.: Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market1.033May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning...
► Artikel lesen
06.05.Zomedica Corp.: Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity1.044Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter. ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Zomedica...
► Artikel lesen
06.05.Zomedica reports Q1 results7
06.05.Zomedica Corp. - 8-K, Current Report3
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1